Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 15/20 | 0.55 |
| ▸ | CHUK | O15111 | 12/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | JAK2 | O60674 | 4/20 | 0.49 |
| ▸ | JAK3 | P52333 | 1/20 | 0.49 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.49 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.49 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.49 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8311363 | 0.95 | IKBKB (0.54) | IKBKBCHUKCCNE1CDK2JAK2 | |
| SCHEMBL8314450 | 0.93 | IKBKB (0.57) | IKBKBCHUK | |
| SCHEMBL8314750 | 0.92 | IKBKB (0.57) | IKBKBCHUK | |
| SCHEMBL14063891 | 0.89 | IKBKB (0.56) | IKBKBCHUK | |
| SCHEMBL8315439 | 0.88 | IKBKB (0.54) | IKBKBCHUKCCNE1CDK2JAK2 | |
| SCHEMBL8313924 | 0.88 | IKBKB (0.55) | IKBKBCHUK | |
| SCHEMBL14063894 | 0.87 | SYK (0.51) | IKBKBCHUKCDK2JAK2JAK3 | |
| SCHEMBL8312297 | 0.87 | IKBKB (0.64) | IKBKBCHUKCCNE1CDK2JAK2 | |
| SCHEMBL8312855 | 0.87 | IKBKB (0.59) | IKBKBCHUKCCNE1CDK2JAK2 | |
| SCHEMBL8312171 | 0.85 | IKBKB (0.54) | IKBKBCHUKCCNE1CDK2JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7429599-B2 | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-09-30 | — | — | US | disclosed |
| US-7429599-B2 | Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2008-09-30 | — | — | US | disclosed |
| WO-2004084901-A1 | METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK | SIGNAL PHARMACEUTICALS, LLC (US) | 2004-10-07 | — | — | WO | disclosed |